DBV Technologies SA (DBVT)
0.691
+0.01
(+1.62%)
USD |
NASDAQ |
Apr 24, 16:00
0.665
-0.03
(-3.76%)
After-Hours: 20:00
DBV Technologies Cash from Investing (TTM): -0.808M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.808M |
| September 30, 2023 | -0.655M |
| June 30, 2023 | -0.181M |
| March 31, 2023 | -0.069M |
| December 31, 2022 | -0.10M |
| September 30, 2022 | -0.54M |
| June 30, 2022 | -0.638M |
| Date | Value |
|---|---|
| March 31, 2022 | -0.237M |
| December 31, 2021 | -0.433M |
| September 30, 2021 | -0.592M |
| June 30, 2021 | -1.428M |
| March 31, 2021 | -2.12M |
| December 31, 2020 | -2.865M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-2.865M
Minimum
Dec 2020
-0.069M
Maximum
Mar 2023
-0.8205M
Average
-0.592M
Median
Sep 2021
Cash from Investing (TTM) Benchmarks
| Edap TMS SA | -4.703M |
| Cellectis SA | -2.021M |
| Biophytis SA | 0.3879M |
| Genfit SA | -- |
| Adaptimmune Therapeutics PLC | 176.54M |